582
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Smoking among patients in substance use disorders treatment: associations with tobacco advertising, anti-tobacco messages, and perceived health risks

, PhD, , MPH, , BA, & , PhD
Pages 649-656 | Received 03 Feb 2016, Accepted 21 Apr 2016, Published online: 17 Jun 2016

References

  • US Department of Health and Human Services. Reducing the health consequences of smoking: 25 Years of progress. A report of the Surgeon General. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, DHHS Publication No. (CDC) 89–8411, 1989.
  • Centers for Disease Control and Prevention. Current cigarette smoking among adults — United States, 2005–2013. Morb Mortal Wkly Rep 2014;63:1118–1112.
  • Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res 2011;13:401–411.
  • Goodwin RD, Sheffer CE, Chartrand H, Bhaskaran J, Hart CL, Sareen J, Bolton J. Drug use, abuse, and dependence and the persistence of nicotine dependence. Nicotine Tob Res 2014;16:1606–1612.
  • Richter KP, Ahluwalia HK, Mosier MC, Nazir N, Ahluwalia JS. A population‐based study of cigarette smoking among illicit drug users in the United States. Addict 2002;97:861–869.
  • Bandiera FC, Anteneh B, Le T, Delucchi K, Guydish J. Tobacco-related mortality among persons with mental health and substance abuse problems. PLoS One 2015;10:e0120581.
  • Apollonio D, Malone RE. Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill. Tob Control 2005;14:409–415.
  • Lee JG, Henriksen L, Rose SW, Moreland-Russell S, Ribisl KM. A systematic review of neighborhood disparities in point-of-sale tobacco marketing. Am J Public Health 2015 ;9:e1–e11.
  • Williams JM, Steinberg ML, Griffiths KG, Cooperman N. Smokers with behavioral health comorbidity should be designated a tobacco use disparity group. Am J Public Health 2013;103:1549–1555.
  • Healton C, Nelson K. Reversal of misfortune: viewing tobacco as a social justice issue. Am J Public Health 2004;94:186–191.
  • Paynter J, Edwards R. The impact of tobacco promotion at the point of sale: a systematic review. Nicotine Tob Res 2009;11:25–35.
  • Henriksen L, Schleicher NC, Feighery EC, Fortmann SP. A longitudinal study of exposure to retail cigarette advertising and smoking initiation. Pediatrics 2010;126:232–238.
  • Robertson L, McGee R, Marsh L, Hoek J. A systematic review on the impact of point-of-sale tobacco promotion on smoking. Nicotine Tob Res 2015;17:2–17.
  • Lovato C, Watts A, Stead LF. Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. Cochrane Database Syst Rev 2011; 10:CD003439.
  • Morgenstern M, Sargent JD, Isensee B, Hanewinkel R. From never to daily smoking in 30 months: the predictive value of tobacco and non-tobacco advertising exposure. BMJ Open 2013;3 :e002907.
  • Hillier A, Chilton M, Zhao Q, Szymkowiak D, Coffman R, Mallya G. Concentration of tobacco advertisements at SNAP and WIC Stores, Philadelphia, Pennsylvania, 2012. Prev Chronic Dis 2015;12 :e15.
  • Allen JA, Duke JC, Davis KC, Kim AE, Nonnemaker JM, Farrelly MC. Using mass media campaigns to reduce youth tobacco use: a review. Am J Health Promot 2015;30:e71–82.
  • Davis RM, Gilpin EA, Loken B, Viswanath K, Wakefield MA. The role of the media in promoting and reducing tobacco use. Bethesda, MD: US: Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Contract No.: NIH Pub. 1994 ( 07-6242). 2008.
  • Durkin S, Brennan E, Wakefield M. Mass media campaigns to promote smoking cessation among adults: an integrative review. Tob Control 2012;21:127–138.
  • Thornton LK, Baker AL, Johnson MP, Kay-Lambkin FJ. Perceptions of anti-smoking public health campaigns among people with psychotic disorders. Ment Health Subst Use 2011;4105–115.
  • Pierce JP, Choi WS, Gilpin EA, Farkas AJ, Berry CC. Tobacco industry promotion of cigarettes and adolescent smoking. JAMA 1998;279:511–515.
  • Gilpin EA, White MM, Messer K, Pierce J. Receptivity to tobacco advertising and promotions among young adolescents as a predictor of established smoking in young adulthood. Am J Public Health 2007;97:1489–1495.
  • Rubinstein ML, Halpern-Felsher BL, Thompson PJ, Millstein SG. Adolescents discriminate between types of smokers and related risks: Evidence from nonsmokers. J Adolescent Res 2003;18:651–663.
  • Halpern-Felsher BL, Biehl M, Kropp RY, Rubinstein ML. Perceived risks and benefits of smoking: differences among adolescents with different smoking experiences and intentions. Prev Med 2004;39:559–567.
  • Guydish J, Yu J, Le T, Pagano A, Delucchi K. Predictors of tobacco use among New York State addiction treatment patients. Am J Public Health 2015;105:e57–e64.
  • Choi WS, Ahluwalia JS, Harris KJ, Okuyemi K. Progression to established smoking: the influence of tobacco marketing. Am J Prev Med 2002;22:228–233.
  • Barnoya J, Colditz, G, Moreland-Russell, S, Cyr, J, Snider, D, & Shootman, M. Prevalence of cigarette advertising and other promotional strategies at the point of sale in St. Louis Missouri: Analysis by store, type and distance from a school. Prev Chronic Dis. 2014;11 :130150.
  • US Food and Drug Administration. Overview of the Family Smoking Prevention and Tobacco Control Act: consumer fact sheet 2013. http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM336940.pdf.
  • Malone R, Grundy Q, Bero LA. Tobacco industry denormalisation as a tobacco control intervention: a review. Tob Control 2015;21:162–170.
  • Mantler T. A systematic review of smoking Youths’ perceptions of addiction and health risks associated with smoking: utilizing the framework of the health belief model. Addict Res Theory 2013;21:306–317.
  • Hammond D. Health warning messages on tobacco products: a review. Tob Control 2011;20:327–337.
  • Frosch DL, Shoptaw S, Nahom D, Jarvik ME. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals Exp Clin Psychopharmacol 2000;8:97–103.
  • Hall SM, Prochaska JJ. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol 2009;5:409–431.
  • Ducharme LJ, Roman PM. Opioid treatment programs in the Clinical Trials Network: representativeness and buprenorphine adoption. J Subst Abuse Treat 2009;37:90–94.
  • McAfee T, Davis KC, Alexander RL, Pechacek TF, Bunnell R. Effect of the first federally funded US antismoking national media campaign. Lancet 2013;382:2003–2011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.